by Inteliquet | Sep 24, 2021 | Uncategorized
Marie E. Lamont, General Manager at Inteliquet™, joins the Oncology Learning Network Podcast to talk about “Inteliquet’s Determined Efforts Through the COVID-19 Landscape.” On this episode, Marie discusses the COVID-19 landscape and how it stalled, delayed, or...
by Inteliquet | Jul 21, 2021 | Uncategorized
“If AI-related technologies can help match real people to the unique needs of trials, doctors, nurses, and others can spend more time connecting one-to-one with potential trial participants, reaffirming the human connections that can be drowned out by paperwork and...
by Inteliquet | Jun 21, 2021 | Uncategorized
“Quick and easy searches through vast databases of cancer patients can save doctors’ time and help pharmaceutical companies find discrete populations of patients for potentially life-saving clinical trials. It’s a solution that can jumpstart research.” -Health IT...
by Inteliquet | Jun 9, 2021 | Uncategorized
“Patient trials are the future of medicine. That future is under threat. Cancer centers and pharmaceutical executives now have the tools to make sure it comes.” -HIT Consultant The coronavirus pandemic caused many clinical trials to shut down and patients to put off...
by Inteliquet | May 19, 2021 | News & Resources, Uncategorized
“Cancer patients deserve our best efforts to provide expanded access to potentially life-saving clinical trial and treatment options. Digital solutions that are proven to fast-track this process are a necessity.” -Health IT Answers In the first four months of...
by Inteliquet | May 11, 2021 | Uncategorized
“Thanks to innovations in cancer research whose development began long before the pandemic, new trial-management solutions are now available—and scalable.” -Enterprise AI Artificial Intelligence (AI) helped develop COVID-19 vaccines at an accelerated speed, and...
